Thrivent Financial for Lutherans’s NuVasive, Inc. NUVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-248,109
| Closed | -$10.3M | – | 2529 |
|
|
2023
Q2 | $10.3M | Sell |
248,109
-5,251
| -2% | -$216K | 0.02% | 637 |
|
|
2023
Q1 | $10.5M | Sell |
253,360
-2,966,154
| -92% | -$127M | 0.03% | 600 |
|
|
2022
Q4 | $133M | Buy |
3,219,514
+647,625
| +25% | +$26.2M | 0.34% | 61 |
|
|
2022
Q3 | $113M | Buy |
2,571,889
+386,996
| +18% | +$18.8M | 0.31% | 70 |
|
|
2022
Q2 | $107M | Buy |
2,184,893
+149,346
| +7% | +$8.01M | 0.29% | 74 |
|
|
2022
Q1 | $115M | Sell |
2,035,547
-111,852
| -5% | -$5.94M | 0.23% | 107 |
|
|
2021
Q4 | $113M | Buy |
2,147,399
+219,982
| +11% | +$12M | 0.22% | 117 |
|
|
2021
Q3 | $115M | Buy |
1,927,417
+505,367
| +36% | +$31.2M | 0.23% | 106 |
|
|
2021
Q2 | $96.4M | Buy |
1,422,050
+3,094
| +0.2% | +$211K | 0.2% | 127 |
|
|
2021
Q1 | $93M | Buy |
1,418,956
+1,014,816
| +251% | +$60.9M | 0.2% | 119 |
|
|
2020
Q4 | $22.8M | Buy |
404,140
+390,336
| +2,828% | +$19.2M | 0.05% | 412 |
|
|
2020
Q3 | $670K | Sell |
13,804
-353
| -2% | -$19K | ﹤0.01% | 1822 |
|
|
2020
Q2 | $788K | Buy |
14,157
+550
| +4% | +$31.8K | ﹤0.01% | 1655 |
|
|
2020
Q1 | $689K | Hold |
13,607
| – | – | ﹤0.01% | 1533 |
|
|
2019
Q4 | $1.05M | Sell |
13,607
-81,506
| -86% | -$5.75M | ﹤0.01% | 1439 |
|
|
2019
Q3 | $6.03M | Buy |
95,113
+2,193
| +2% | +$137K | 0.02% | 639 |
|
|
2019
Q2 | $5.44M | Sell |
92,920
-33,844
| -27% | -$2M | 0.02% | 677 |
|
|
2019
Q1 | $7.2M | Sell |
126,764
-430,068
| -77% | -$22.9M | 0.02% | 578 |
|
|
2018
Q4 | $27.6M | Buy |
556,832
+36,156
| +7% | +$2.17M | 0.1% | 227 |
|
|
2018
Q3 | $37M | Sell |
520,676
-7,992
| -2% | -$509K | 0.12% | 193 |
|
|
2018
Q2 | $27.6M | Buy |
528,668
+5,559
| +1% | +$291K | 0.09% | 226 |
|
|
2018
Q1 | $27.3M | Buy |
523,109
+3,734
| +0.7% | +$189K | 0.09% | 205 |
|
|
2017
Q4 | $30.4M | Buy |
519,375
+205
| +0% | +$11.6K | 0.1% | 188 |
|
|
2017
Q3 | $28.8M | Sell |
519,170
-34,970
| -6% | -$2.31M | 0.1% | 191 |
|
|
2017
Q2 | $42.6M | Sell |
554,140
-41,640
| -7% | -$3.11M | 0.18% | 135 |
|
|
2017
Q1 | $44.5M | Sell |
595,780
-551
| -0.1% | -$40K | 0.19% | 126 |
|
|
2016
Q4 | $40.2M | Sell |
596,331
-880
| -0.1% | -$56.7K | 0.18% | 135 |
|
|
2016
Q3 | $39.8M | Sell |
597,211
-13,210
| -2% | -$841K | 0.18% | 142 |
|
|
2016
Q2 | $36.5M | Sell |
610,421
-70,119
| -10% | -$3.79M | 0.17% | 137 |
|
|
2016
Q1 | $33.1M | Buy |
680,540
+48,110
| +8% | +$2.18M | 0.16% | 145 |
|
|
2015
Q4 | $34.2M | Buy |
632,430
+720
| +0.1% | +$36.7K | 0.16% | 136 |
|
|
2015
Q3 | $30.5M | Buy |
631,710
+118,450
| +23% | +$6.12M | 0.16% | 145 |
|
|
2015
Q2 | $24.3M | Sell |
513,260
-152,860
| -23% | -$7.15M | 0.13% | 178 |
|
|
2015
Q1 | $30.6M | Sell |
666,120
-2,950
| -0.4% | -$137K | 0.17% | 148 |
|
|
2014
Q4 | $31.6M | Sell |
669,070
-218,880
| -25% | -$9.12M | 0.17% | 145 |
|
|
2014
Q3 | $31M | Buy |
887,950
+55,440
| +7% | +$1.97M | 0.18% | 137 |
|
|
2014
Q2 | $29.6M | Buy |
832,510
+112,620
| +16% | +$3.85M | 0.17% | 143 |
|
|
2014
Q1 | $27.7M | Buy |
719,890
+49,760
| +7% | +$1.83M | 0.17% | 142 |
|
|
2013
Q4 | $21.7M | Buy |
670,130
+25,980
| +4% | +$780K | 0.13% | 171 |
|
|
2013
Q3 | $15.8M | Buy |
644,150
+440,250
| +216% | +$10.8M | 0.1% | 218 |
|
|
2013
Q2 | $5.05K | Buy |
+203,900
| New | +$4.46M | 0.03% | 426 |
|
Other funds holding NUVA
Thrivent Financial for Lutherans's NUVA Position: Q3 2023 in Review
Thrivent Financial for Lutherans sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 248,109 shares — an estimated $10.3M sold.
Thrivent Financial for Lutherans first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $133M in Q4 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.
- Thrivent Financial for Lutherans reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 248,109 NuVasive, Inc. shares in Q3 2023, an estimated $10.3M.
- Thrivent Financial for Lutherans first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
- Thrivent Financial for Lutherans's NuVasive, Inc. position peaked at $133M in Q4 2022.
- 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.
Based on Thrivent Financial for Lutherans's 13F filing for Q3 2023, filed 14 Nov 2023.